Melanoma Institute Australia celebrates International Women's Day
8 March 2017
To celebrate International Women's Day, we're sharing how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
Meet Danielle Fischer, our Science Communications Specialist.
"I wanted my career to make a difference to people, and I always had a passion for science, so studying Medical Science at uni was the obvious choice. After a few years working in the lab, I decided I enjoyed talking about research rather than actually doing it! And so by accident, I stumbled into Science Communications – a field I never knew existed while studying. It’s the perfect mix for me and I enjoy translating complex medical research for the general public to appreciate. I particularly like translating research that gives hope to patients."
This is Tuba Nur Gide, PhD student and winner of NSW National Council of Women Australia Day Award for her research focused on the role of immunotherapies in melanoma.
"My parents raised me to work hard, be independent and do well academically – they value education very highly. I think that’s why even as a little girl, I knew that I wanted to pursue completing a PhD, in whatever field of study I would end up choosing.
Having been awarded a PhD Scholarship from MIA two years in a row now is an opportunity that I am truly humbled by. Knowing people close to me that have been affected by cancer drives me even further to do the very best that I can.
I believe that it’s really important for females to have equal opportunity. All women should be valued as individuals. We’re strong, we’re smart and no one should push us around. Careers shouldn’t be defined by your gender and I hope that in the future, education opportunities offered to young boys and girls are free of gender bias or sexism.”
Maria Gonzalez, Clinical Trials Manager here at MIA.
"I completed an undergraduate degree in nursing at The University of Sydney and further postgraduate studies in health science. I am fortunate to have accessed training and education which has enabled me to pursue a career combining both cancer care and clinical research.
Women make up about 90% of Australia’s nursing workforce and play a pivotal role in clinical care and research. Today I will be bold and celebrate the valuable contribution and achievements of all nurses in the fight against cancer."
"International collaboration remains the key to ensuring this pioneering research continues so we can increase survival rates for advanced melanoma patients and move us closer to achieving our goal of zero deaths from melanoma," says Professor Georgina Long, of the clinical trial results presented at ESMO 2018.
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich.
A larger, monthly dose of immunotherapy can give melanoma patients more freedom without sacrificing effectiveness.
The Australasian Melanoma Conference, hosted by the Australasian Melanoma Conference Committee, was held in Melbourne on the weekend, with many of MIA's clinicians in attendance.
The two men who discovered checkpoint inhibitors, the brakes of the immune system, were awarded the Nobel Prize in Physiology or Medicine on Monday, October 1.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.